PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Phenotype | C0020514|hyperprolactinemia |
| Sentences | 6 |
| PubMedID- 24023549 | Objective: this study aimed to assess the efficacy of aripiprazole for the management of cognitive impairments and hyperprolactinemia in patients with schizophrenia on a stable dose of risperidone. |
| PubMedID- 26448615 | The present study shows that adjunctive aripiprazole treatment in schizophrenia patients with risperidone-induced hyperprolactinemia results in a significant reduction in plasma concentrations of prolactin. |
| PubMedID- 21253412 | There have been many reports that hyperprolactinemia happens in patients with chronic schizophrenia who have taken typical antipsychotics and risperidone for a long period in the past, and the decrease of bone mineral density is observed in such patients.16-18 the incidence was greater among the female menopausal patients who underwent a drastic change in sex hormones. |
| PubMedID- 26587235 | A randomized, double blind trial of 119 schizophrenia patients with risperidone-induced hyperprolactinemia investigated the dose response relationship between aripiprazole and prolactin levels. |
| PubMedID- 22172534 | This study aimed to estimate the prevalence of sexual dysfunction, evaluated by the nagoya sexual function questionnaire (nsfq), and hyperprolactinemia in patients with schizophrenia and examine a relationship between sexual dysfunction and serum prolactin levels. |
| PubMedID- 20871665 | Antipsychotic-induced hyperprolactinemia in adults with schizophrenia has been associated with reduced bmd and increased fracture risk [36, 37]. |
Page: 1